TI
TENX icon

Trexquant Investment’s Tenax Therapeutics TENX Stock Holding History

Trexquant Investment’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Buy
321,604
+270,892
+534% +$3.46M 0.03% 782
2026
Q1 		$811K Buy
+50,712
New +$686K 0.01% 1303

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Trexquant Investment's TENX Position: Q2 2026 in Review

Trexquant Investment increased its Tenax Therapeutics (TENX) stake by 534% in Q2 2026, buying an estimated $3.46M and bringing the position to 321,604 shares worth $4.68M. The position accounts for 0.03% of the portfolio, ranked #782.

Trexquant Investment first reported a position in TENX in Q1 2026 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Trexquant Investment held 321,604 shares of Tenax Therapeutics worth $4.68M as of Q2 2026.
  • Trexquant Investment bought 270,892 Tenax Therapeutics shares in Q2 2026, an estimated $3.46M.
  • Tenax Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #782 holding.
  • Trexquant Investment first reported a position in Tenax Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.